Dental Care Clinics in Walsenbrug, CO Accepting Medicare
1 Dental Care Clinics found. Showing 1 - 1
 Dennis P. Driscoll Dds Dentist Medicare: Not Enrolled in Medicare Practice Location: 129 Kansas Ave, Walsenbrug, CO 81089 Phone: 719-252-1822 Fax: 719-676-3306 |
News Archive
Women are better than men at distinguishing between emotions: Study
Women are better than men at distinguishing between emotions, especially fear and disgust, according to a new study published in the online version of the journal Neuropsychologia. As part of the investigation, Olivier Collignon and a team from the Universit- de Montr-al Centre de recherche en neuropsychologie et cognition (CERNEC) demonstrated that women are better than men at processing auditory, visual and audiovisual emotions.
Study sheds light on the origin of most common and prevalent form of Alzheimer's disease
After a decade of work, a team led by Hôpital Maisonneuve-Rosemont researcher and Université de Montréal associate professor Dr. Gilbert Bernier has shed promising light on the origin of the most common and prevalent form of Alzheimer's disease, hoping to someday help mitigate or even reverse the progress of the disease.
China Pharma revenue increases 9% to $81.2M for full year 2011
China Pharma Holdings, Inc., a fully-integrated specialty pharmaceuticals company in China, today announced financial results for the year ended December 31, 2011.
Scientist suggests emodin can reduce impact of type 2 diabetes
Emodin, a natural product that can be extracted from various Chinese herbs including Rheum palmatum and Polygonum cuspidatum, shows promise as an agent that could reduce the impact of type 2 diabetes. Findings published in this month's edition of the British Journal of Pharmacology show that giving emodin to mice with diet-induced obesity lowered blood glucose and serum insulin, improved insulin resistance and lead to more healthy levels of lipid in the blood. It also decreased body weight and reduced central fat mass.
GTC Biotherapeutics reports total net loss of $1.7M for fourth-quarter 2009
GTC Biotherapeutics, Inc. today reported its financial results for the fourth quarter and fiscal year ended January 3, 2010. The total net loss for the fourth quarter was $1.7 million, or $0.09 per share, compared with $6.2 million, or $0.60 per share, for the fourth quarter of 2008. The total net loss for 2009 was $27.9 million, or $2.18 per share, compared to $22.7 million, or $2.31 per share, for 2008.
› Verified 8 days ago